オメガ3サプリメントの世界市場 - 2024年～2031年

概要

オメガ3サプリメントの世界市場は2023年に72億米ドルに達し、2031年には141億米ドルに達すると予測され、予測期間2024年～2031年のCAGRは7.1%で成長する見込みです。

オメガ3サプリメント市場は、心臓の健康や脳の機能をサポートし、炎症を抑えるEPAやDHAなどのオメガ3脂肪酸の健康効果に対する消費者の意識の高まりによって、力強い成長を遂げています。健康意識の高い消費者が予防的な解決策を求める中、特に心血管疾患の有病率の高まりと高齢化により、オメガ3系脂肪酸の需要は増加の一途をたどっています。

米国食品医薬品局は、栄養補助食品からEPAとDHAを合わせて1日5グラム以内の摂取を推奨しているが、これはオメガ3サプリメント市場の形成に重要な役割を果たしています。加えて、藻類由来のオメガ3など植物由来の選択肢の拡大が、菜食主義者や環境意識の高い消費者のニーズに応えています。世界的に健康志向が強まる中、オメガ3サプリメントは世界の予防健康戦略に不可欠な存在であり続けようとしています。

アメリカの成人は、ALAを1.98g/日摂取しており、推奨摂取量を超えているが、EPAは35mg/日、DHAは76mg/日しか摂取しておらず、推奨レベルを大きく下回っています。EPAとDHAの摂取量におけるこの大きなギャップは、世界のオメガ3サプリメント市場において北米が優位を保ち続けていることを裏付けています。消費者がこれらの重要な栄養ニーズを満たすために、ますますサプリメントに頼るようになっています。

ダイナミクス

消費者の健康志向の高まり

オメガ3脂肪酸の健康効果、特に心臓の健康、脳機能、炎症抑制に対する消費者の意識の高まりにより、市場は急速な成長を遂げています。より多くの人々が予防医療に注目し、積極的に健康を管理する方法を模索する中、オメガ3サプリメントは定番となりつつあり、市場の継続的な拡大を支えています。慢性疾患、特に心血管疾患の有病率の上昇と人口の高齢化が需要をさらに押し上げています。

サプリメントの消費動向は、自然な健康解決策への傾向の高まりをさらに反映しています。Council for Responsible Nutritionによると、2021年にはオメガ3などの特殊サプリメントがサプリメント消費の46%を占めるといいます。市場の成長は、過去40年間で25%から70%に急増した栄養補助食品使用の世界の増加とも関連しています。慢性疾患のリスクが高い人口が特にこの動向を後押ししています。

新たなイノベーション

オメガ3サプリメントの革新は、世界市場の成長を促進する上で極めて重要です。オメガ3脂肪酸の生物学的利用能と吸収を高める技術の進歩は、より効果的で便利な健康ソリューションに対する消費者の需要の高まりに応えています。その代表例がアーカー・バイオマリンのPL+EPA/DHA製剤で、従来の魚油に比べてEPAとDHAの吸収率を10.5倍と大幅に高めています。

オキアミのリン脂質と魚油を組み合わせたこの画期的な製剤は、脂肪分の多い食事を摂らなくても消化吸収が良くなります。低脂肪食を摂る人の増加に対応し、より効率的なサプリメントを提供することで、このような技術革新は市場の裾野を広げています。消費者の健康志向が高まり、科学的裏付けのある持続可能で効率的な製品を求めるようになるにつれ、PL+技術のようなイノベーションが市場の成長を加速させています。

高コストと持続可能性の課題

高品質のオメガ3製品の高コストは、世界のオメガ3サプリメント市場にとって最も大きな阻害要因の一つです。特に魚油に由来するプレミアム・オメガ3製品は、高価な抽出工程と高品質・高濃度のEPAとDHAを必要とするため、製造コストが高くなることが多いです。その結果、これらの製品は割高な価格で販売され、価格に敏感な消費者には手が届きにくいものとなっています。

さらに、持続可能で倫理的に調達されたオメガ3系食品に対する需要の高まりが、さらなる価格上昇につながっています。乱獲の懸念や環境持続可能性への取り組みにより、責任ある養殖魚や藻類油のような植物由来の代替品の使用など、より良い調達方法が求められています。こうした代替品は環境にやさしいとされることが多いが、生産コストが高くなり、価格がさらに上昇する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 消費者の健康意識の高まり
    • 新しいイノベーション
  • 抑制要因
    • 高コストと持続可能性の課題
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• DMIの見解

第6章 供給源別

• 魚油
• オキアミオイル
• 藻類油
• その他

第7章 形態別

• ソフトジェルカプセル
• 液体
• 粉末

第8章 タイプ別

• オーガニック
• 従来型

第9章 機能別

• 心臓血管の健康
• 脳と認知の健康
• 目の健康
• 関節の健康
• その他

第10章 流通チャネル別

• スーパーマーケット/ハイパーマーケット
• コンビニエンスストア
• 専門店
• オンラインストア
• その他

第11章 エンドユーザー別

• 成人
• 妊婦
• 子供
• 高齢者
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第13章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第14章 企業プロファイル

• Nordic Naturals Inc
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• RB Health（US）LLC
• Aker BioMarine Human Ingredients AS
• dsm-firmenich
• NOW Foods
• Pharmavite LLC
• Carlson Labs
• The Coromega Company
• NutriGold Inc
• Barlean's Organic Oils, LLC

第15章 付録

Overview

Global Omega-3 Supplements Market reached US$ 7.2 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 7.1 % during the forecast period 2024-2031.

The omega-3 supplements market is experiencing robust growth, driven by increasing consumer awareness of the health benefits of omega-3 fatty acids like EPA and DHA, which support heart health and brain function and reduce inflammation. As health-conscious consumers seek preventive solutions, demand for omega-3s continues to rise, particularly due to the growing prevalence of cardiovascular diseases and the aging population.

The US Food and Drug Administration's recommendation of consuming no more than 5 grams per day of EPA and DHA combined from dietary supplements plays a crucial role in shaping the Omega-3 supplements market. Additionally, the expanding availability of plant-based options, such as algae-derived omega-3s, is meeting the needs of vegan and environmentally-conscious consumers. As the global focus on wellness intensifies, omega-3 supplements are poised to remain vital to preventive health strategies worldwide.

American adults consume 1.98 grams/day of ALA, exceeding the recommended intake, but only 35 mg/day of EPA and 76 mg/day of DHA, well below recommended levels. This significant gap in EPA and DHA intake supports North America's continued dominance in the global omega-3 supplements market, as consumers increasingly turn to supplements to meet these vital nutritional needs.

Dynamics

Increasing Consumer Health Consciousness

The market is experiencing rapid growth, driven by rising consumer awareness of the health benefits of omega-3 fatty acids, particularly for heart health, brain function and inflammation reduction. As more people focus on preventive health and seeking ways to manage their health proactively, omega-3 supplements are becoming a staple, supporting the continued expansion of the market. The increasing prevalence of chronic diseases, especially cardiovascular issues and the aging population have further fueled demand.

Supplements consumption is further reflecting a growing trend toward natural health solutions. According to the Council for Responsible Nutrition, specialty supplements like Omega-3s accounted for 46% of supplement consumption in 2021. The market growth is also linked to the broader increase in dietary supplement use worldwide, which has surged from 25% to 70% over the past 40 years. Populations at higher risk for chronic conditions are particularly driving this trend.

New Innovations

Innovations in omega-3 supplementation are pivotal in driving the growth of the global market. Advances in technology that enhance the bioavailability and absorption of omega-3 fatty acids are meeting the increasing consumer demand for more effective and convenient health solutions. A prime example is Aker BioMarine's PL+ EPA/DHA formulation, which significantly boosts the absorption of EPA and DHA by 10.5 times compared to traditional fish oil.

The breakthrough formulation, which combines krill phospholipids and fish oil, allows for better digestion and absorption, even without needing a fatty meal. By catering to the growing number of individuals on low-fat diets and offering a more efficient supplement, such innovations are expanding the market's reach. As consumers become more health-conscious and seek scientifically-backed, sustainable and efficient products, innovations like PL+ technology are accelerating market growth.

High Costs and Sustainability Challenges

The high cost of quality Omega-3 products is one of the most significant hindering factors for the global Omega-3 supplements market. Premium Omega-3 supplements, particularly those derived from fish oil, often have higher production costs due to the expensive extraction processes and the need for high-quality, concentrated EPA and DHA. As a result, these products are sold at a premium price, making them less affordable for price-sensitive consumers.

Additionally, the growing demand for sustainable and ethically sourced Omega-3s has led to further price increases. Overfishing concerns and environmental sustainability efforts are pushing for better sourcing practices, such as using responsibly farmed fish or plant-based alternatives like algae oil. While these alternatives are often considered more eco-friendly, they can be costlier to produce, further driving up prices.

Segment Analysis

The global Omega-3 supplements market is segmented based on source, form, type, functionality, distribution channel, end-user and region.

High Concentration Of Essential Fatty Acids in Fish Oil

The global Omega-3 supplements market is segmented based on source into fish oil, krill oil, algae oil and others. The fish oil segment dominates the global omega-3 supplements market due to its high concentration of essential fatty acids, EPA and DHA, which are widely recognized for their health benefits, including improving heart health, reducing inflammation and supporting brain function. Fish oil is the most bioavailable and concentrated source of these Omega-3s, making it the preferred choice for consumers.

Extensive research and strong scientific evidence have built consumer trust in its efficacy, ensuring its position as the leading source of Omega-3 supplements. Additionally, fish oil is more cost-effective than alternatives like krill oil and algae oil, making it accessible to a larger consumer base, particularly in developing markets leading to new product launches adding to its dominance.

For instance the launch of NOW's Omega-3 Gummy Chews in August 2024. These sugar-free gummies provide 750 mg of fish oil with enhanced bioavailability, meeting strict purity and potency standards. Offering an affordable, high-quality health solution, they cater to consumers looking for convenient, effective Omega-3 supplementation. The product's availability both online and in select stores underscores the demand for accessible fish oil-based supplements.

Geographical Penetration

Increasing Health-Consciousness in North America

North America's dominance in the global omega-3 supplements market is supported by a well-established culture of health-consciousness, where supplements play a key role in daily wellness routines. According to the 2023 CRN Consumer Survey on Dietary Supplements, 74% of US adults take dietary supplements, with 55% considered regular users, highlighting Americans' mainstream acceptance of supplements.

The trend reflects a growing awareness of the health benefits of products like omega-3s, which are known to support heart health, reduce inflammation and improve brain function. The increasing reliance on supplements is driven by a preventive healthcare mindset, with many consumers seeking to enhance their overall well-being before health issues arise. Region's highly developed healthcare infrastructure and pharmaceutical companies continuously developing and promoting Omega-3 supplements.

Competitive Landscape

The major global players in the market include Nordic Naturals Inc, RB Health (US) LLC, Aker BioMarine Human Ingredients AS, dsm-firmenich, NOW Foods, Pharmavite LLC, Carlson Labs, The Coromega Company, NutriGold Inc and Barlean's Organic Oils, LLC.

Sustainability Analysis

The Omega-3 supplements market is growing rapidly, driven by rising demand for health benefits like improved heart health and brain function. However, the environmental impact of sourcing Omega-3, mainly from fish oil, raises concerns about overfishing. To address this, companies are adopting sustainable practices, such as sourcing from certified fisheries or using algae-based alternatives, to meet consumer demand for eco-friendly products.

As consumers increasingly prioritize ethical sourcing and transparency, brands are focusing on fair labor practices and responsible supply chains. Sustainability is also becoming a key competitive advantage, with many consumers willing to pay more for environmentally and socially responsible products. Balancing health benefits with sustainability is becoming crucial for the long-term success of the market.

Key Developments

• In March 2024, Epax launched EPAX Omega 3-9-11, a concentrated oil combining omega-3s, omega-9 and omega-11 fatty acids. Using advanced EQP+ Tech, it targets skin health by improving barrier function and reducing inflammation, while offering broader metabolic benefits.
• In January 2024, Ritual launched Omega-3 DHA + EPA, a vegan supplement with 500 mg of omega-3s in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in France, it's designed for minimal burp-back with a natural citrus flavor. Third-party tested, gluten-free, soy-free and packaged in 100% recycled materials.

Why Purchase the Report?

• To visualize the global Omega-3 supplements market segmentation based on source, form, type, functionality, distribution channel, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous Omega-3 supplements market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global omega-3 supplements market report would provide approximately 86 tables, 88 figures and 211 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Source
• 3.2. Snippet by Form
• 3.3. Snippet by Type
• 3.4. Snippet by Functionality
• 3.5. Snippet by Distribution Channel
• 3.6. Snippet by End-User
• 3.7. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Consumer Health Consciousness
    • 4.1.1.2. New Innovations
  • 4.1.2. Restraints
    • 4.1.2.1. High Costs and Sustainability Challenges
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. By Source

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 6.1.2. Market Attractiveness Index, By Source
• 6.2. Fish Oil
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Krill Oil
• 6.4. Algae Oil
• 6.5. Others

7. By Form

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 7.1.2. Market Attractiveness Index, By Form
• 7.2. Soft Gel Capsules
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Liquid
• 7.4. Powder

8. By Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.1.2. Market Attractiveness Index, By Type
• 8.2. Organic
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Conventional

9. By Functionality

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 9.1.2. Market Attractiveness Index, By Functionality
• 9.2. Cardiovascular Health
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Brain & Cognitive Health
• 9.4. Eye Health
• 9.5. Joint Health
• 9.6. Others

10. By Distribution Channel

• 10.1. Introduction
• 10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
• 10.3. Market Attractiveness Index, By Distribution Channel
• 10.4. Supermarkets/Hypermarkets
  • 10.4.1. Introduction
  • 10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.5. Convenience Stores
• 10.6. Specialty Stores
• 10.7. Online Stores
• 10.8. Others

11. By End-User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.1.2. Market Attractiveness Index, By End-User
• 11.2. Adults
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3. Pregnant Women
• 11.4. Children
• 11.5. Elderly
• 11.6. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.2.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.10.1. US
    • 12.2.10.2. Canada
    • 12.2.10.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.10.1. Germany
    • 12.3.10.2. U.K.
    • 12.3.10.3. France
    • 12.3.10.4. Italy
    • 12.3.10.5. Spain
    • 12.3.10.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.4.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.10.1. Brazil
    • 12.4.10.2. Argentina
    • 12.4.10.3. Rest of South America
• 12.5. Asia-Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.5.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.10.1. China
    • 12.5.10.2. India
    • 12.5.10.3. Japan
    • 12.5.10.4. Australia
    • 12.5.10.5. Rest of Asia-Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.6.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

• 13.1. Competitive Scenario
• 13.2. Market Positioning/Share Analysis
• 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

• 14.1. Nordic Naturals Inc
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Financial Overview
  • 14.1.4. Key Developments
• 14.2. RB Health (US) LLC
• 14.3. Aker BioMarine Human Ingredients AS
• 14.4. dsm-firmenich
• 14.5. NOW Foods
• 14.6. Pharmavite LLC
• 14.7. Carlson Labs
• 14.8. The Coromega Company
• 14.9. NutriGold Inc
• 14.10. Barlean's Organic Oils, LLC

LIST NOT EXHAUSTIVE

15. Appendix

• 15.1. About Us and Services
• 15.2. Contact Us